solvecfs.org


Tags Whois Backlink & Rankings Speed Safety Headers Similar Sites Keywords H Tags
Tags Whois Rank Speed Safety Headers Similar Sites Keywords H Tags

solvecfs.org Website Info

solvecfs.org (Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.) was registered first at 2009-03-05 17:39:08. DNS looks Active and website looks Accessable. solvecfs.org Website SEMRush Rank is 300,100. solvecfs.org seems popular on facebook. According to Google, website speed score is 4/100 and AVERAGE. Website looks safe for children. We detected the website language as en-US.
solvecfs.org


solvecfs.org Website Tags

Domain Status:
✓ Active
Is Site Accessable?:
✓ Yes
SSL(https):
✓ Yes
Accessable Url:
https://solvecfs.org
Title:
Home - Solve ME/CFS Initiative
Description:
Solve M.E. is a non-profit org focused on myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), Long Covid and other post-infection diseases.
Categories :
Business, Health and Wellness
External Links:
16
Internal Links:
133
Canonical URL:
https://solvecfs.org/
Language:
en-US
XML Sitemap:
✓ Yes
robots.txt:
✓ Yes https://solvecfs.org/robots.txt
Favicon:
✓ Yes

solvecfs.org Domain & Whois Details

Refresh
Domain Create Date:
2009-03-05 17:39:08
Domain Age:
16 years, 3 months, 28 days
Domain Owner:
Sponsoring Register.com, Inc. (R71-LROR)Registrant Kristina HopkinsAdmin PERFECT PRIVACY, LLCTech PERFECT PRIVACY, LLC
Server Software:
PHP/5.3.29
Server Type:
Apache/2.2.22
Nameservers:
NS1.MEDIATEMPLE.NET - NS2.MEDIATEMPLE.
Hosting Location:
US - UNITED STATES
IP:
64.207.139.110

solvecfs.org Backlinks & Rankings

SEMRush Rank:
300,100
Semrush Rank is a proprietary score that lets you find the domains that are getting the most traffic from organic search.
SEMRush Traffic:
5,231
Number of users expected to visit the website during the following month.
SEMRush Costs:
6,241
Estimated price of organic keywords in Google AdWords.
SEMRush URL Links:
1,013
Number of links to URL according to SemRush.
SEMRush Website Links:
24,509
Number of links to the website according to SemRush.
SEMRush Domain Links:
25,752
Number of links to SemRush Domain.
SEMRush Keywords In Top 100:
3,739
Number of keywords where site in Google's organic search top 100.

solvecfs.org Social Media

Facebook Comments:
416
Facebook Shares:
4,122
Facebook Reactions:
968

solvecfs.org Website Speed (Desktop)

Refresh
Overall Category:
AVERAGE
The human readable speed "category"
Speed Index:
4
Speed Index shows how quickly the contents of a page are visibly populated. [Learn more about the Speed Index metric].
Cumulative Layout Shift (CLS):
0.08 (FAST)
The Cumulative Layout Shift (CLS) metric measures how much unexpected layout shifts affect the user experience on a page. These layout shifts occur when content moves around without prior user input. CLS
Time to First Byte (TTFB):
1.185 s (AVERAGE)
TTFB (time to first byte) is the number of milliseconds it takes for a client’s browser to receive the first byte of the response from the web server. Usually, TTFB can be improved with faster hosting and server optimizations. TTFB
First Input Delay (FID):
3 ms (FAST)
First Input Delay (FID) measures the time from when the user interacts with your site for the first time (click a link, tap on a button, etc.) to the time when the browser is able to respond to that interaction. Google recommends keeping FID below 100ms for a good user experience. FID
First Contentful Paint (FCP):
2.128 s (AVERAGE)
FCP (First Contentful Paint) measures the time from a user’s navigation to when the browser renders the first bit of content from the DOM. In other words, FCP marks the time at which the first text or image is painted for the user. According to PageSpeed Insights, FCP should occur in under 2 seconds. FCP
Interaction to Next Paint (INP):
80 ms (FAST)
Interaction to Next Paint (INP) is a web performance metric that measures user interface responsiveness – how quickly a website responds to user interactions like clicks or key presses. Specifically, it measures how much time elapses between a user interaction like a click or key press and the next time the user sees a visual update on the page. INP
Largest Contentful Paint (LCP):
2.607 s (AVERAGE)
Largest Contentful Paint (LCP) is a metric that measures when the largest content in the viewport is rendered. It is used to measure how long it takes for the main content of your webpage to appear on the screen. Everything below 2.5s is considered good LCP time by PageSpeed Insights. LCP
Total Size:
5958 KB
Total Size. Large network payloads cost users real money and are highly correlated with long load times.
Server Response Time:
149 ms
Initial server response time. Keep the server response time for the main document short because all other requests depend on it. [Learn more about the Time to First Byte metric](https://developer.chrome.com/docs/lighthouse/performance/time-to-first-byte/).
Final Url:
https://solvecfs.org/
Canonicalized and final URL for the document, after following page redirects (if any).
Last Date Checked:
7/5/2023 5:48:57 PM
The last time we checked this website.
Site Speed Check(Full)

solvecfs.org HTML Resources

Type
Request Count
Size
Total
179
5,958 KB
Third-party
59
2,529 KB
Image
22
2,528 KB
Script
71
2,436 KB
Font
10
380 KB
Stylesheet
57
353 KB
Document
3
189 KB
Other
16
70 KB
Media
0
0 KB

solvecfs.org Website Safety

Refresh
Last Check Date:
6/15/2023 2:23:26 PM
Fortiguard:
Health and Wellness
Mcafee Category:
Business
OpenDNS:
BeFirst
Cloudflare DNS:
OK
MyWot Child Safety:
88

solvecfs.org HTTP Headers

Refresh
Accept-Ranges :
bytes
Age :
12645
Cache-Control :
max-age=0, s-maxage=2592000
Cache-Provider :
CLOUDWAYS-CACHE-DE
Connection :
keep-alive
Content-Length :
683215
Content-Type :
text/html; charset=utf-8
Date :
Sun, 04 Jun 2023 08:48:10 GMT
expires :
Sun, 04 Jun 2023 05:17:25 GMT
Last-Modified :
Thu, 01 Jun 2023 21:40:42 GMT
Server :
nginx
Vary :
Accept-Encoding,Accept-Encoding
X-Cache :
HIT


solvecfs.org W3C HTML Validation Check Now

Last Check Date:
5/29/2023 12:00:00 AM
Errors:
49
Warnings:
0
Info:
37
Check Live:
Check solvecfs.org HTML Errors

solvecfs.org Similar Sites

Website
Title
Rank
meassociation.org.uk meassociation.org.uk
The ME Association - The ME Association
406,201
meaction.net meaction.net
Home - #MEAction Network
omf.ngo omf.ngo
omf home - open medicine foundation
194,875
me-pedia.org me-pedia.org
MEpedia
47,097
meresearch.org.uk meresearch.org.uk
MeResearch.org.uk | Medical Research & Healthcare Insights
1,006,315
Top solvecfs.org Alternatives

solvecfs.org Site Keywords

Leading the Fight to Cure ME/CFS
Solve ME/CFS initiative

solvecfs.org Site H Tags

Check Now
h1
Survey: How Has Long Covid Impacted Your Life?
h1
Making Breakthroughs Possible
h2
Iowa
h2
Washington D.C.
h2
Maine
h2
Louisiana
h2
Kentucky
h2
Kansas
h2
Ohio
h2
North Dakota
h2
North Carolina
h2
New York
h2
New Mexico
h2
New Jersey
h2
New Hampshire
h2
Nevada
h2
Nebraska
h2
Montana
h2
Missouri
h2
Mississippi
h2
Minnesota
h2
Michigan
h2
Massachusetts
h2
Maryland
h2
Indiana
h2
What are ME/CFS & Long Covid?
h2
Core Programs
h2
Take Action Now!
h2
Solve Launches First National Long Covid PSA
h2
Long Covid's Prevalence and Economic Impact
h2
Long Covid: What Will It Take to Accelerate Therapeutic Progress?
h2
Long Haul Voices: Living with Long Covid and ME/CFS
h2
About Us
h2
Illinois
h2
Idaho
h2
Hawaii
h2
Georgia
h2
Florida
h2
Delaware
h2
Connecticut
h2
Colorado
h2
California
h2
Arkansas
h2
Arizona
h2
Alaska
h2
Oregon
h2
Alabama
h2
Washington
h2
Wyoming
h2
Wisconsin
h2
West Virginia
h2
Virginia
h2
Vermont
h2
Utah
h2
Texas
h2
Tennessee
h2
South Dakota
h2
South Carolina
h2
Rhode Island
h2
Pennsylvania
h2
Oklahoma
h4
Solve ME/CFS Initiative
h4
Explore
h4
Donate
h4
Join our newsletter
h4
Privacy Overview
h4
Groundbreaking Research
h4
Harnessing the Power of Big Data
h4
Inspiring Advocacy
h4
Forging Alliances
h4
The most prevalent diseases you’ve never heard of
h5
Cumulative Cost to Jan 31, 2022: $700M
h5
% of Population with Long Covid: 5.6%
h5
% of Population with Disabling Long Covid: 1.9%
h5
# of Individuals with Long Covid: 38,000
h5
# of Individuals with Disabling Long Covid: 13,000
h5
Cumulative Cost to Jan 31, 2022: $3.9B
h5
% of Population with Long Covid: 6.8%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 214,000
h5
# of Individuals with Disabling Long Covid: 71,000
h5
Cumulative Cost to Jan 31, 2022: $3.9B
h5
% of Population with Long Covid: 7.4%
h5
% of Population with Disabling Long Covid: 2.5%
h5
# of Individuals with Long Covid: 216,000
h5
# of Individuals with Disabling Long Covid: 72,000
h5
Cumulative Cost to Jan 31, 2022: $6.1B
h5
% of Population with Long Covid: 7.8%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 344,000
h5
# of Individuals with Disabling Long Covid: 114,000
h5
Cumulative Cost to Jan 31, 2022: $5.9B
h5
% of Population with Long Covid: 7.1%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 330,000
h5
# of Individuals with Disabling Long Covid: 110,000
h5
Cumulative Cost to Jan 31, 2022: $940M
h5
% of Population with Long Covid: 3.9%
h5
% of Population with Disabling Long Covid: 1.3%
h5
# of Individuals with Long Covid: 52,000
h5
# of Individuals with Disabling Long Covid: 17,000
h5
Cumulative Cost to Jan 31, 2022: $5.2B
h5
% of Population with Long Covid: 4.7%
h5
% of Population with Disabling Long Covid: 1.6%
h5
# of Individuals with Long Covid: 281,000
h5
# of Individuals with Disabling Long Covid: 93,000
h5
Cumulative Cost to Jan 31, 2022: $8.6B
h5
% of Population with Long Covid: 6.9%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 472,000
h5
# of Individuals with Disabling Long Covid: 156,000
h5
Cumulative Cost to Jan 31, 2022: $12B
h5
% of Population with Long Covid: 6.7%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 669,000
h5
# of Individuals with Disabling Long Covid: 222,000
h5
Cumulative Cost to Jan 31, 2022: $7B
h5
% of Population with Long Covid: 7.1%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 391,000
h5
# of Individuals with Disabling Long Covid: 130,000
h5
Cumulative Cost to Jan 31, 2022: $3.9B
h5
% of Population with Long Covid: 7.2%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 216,000
h5
# of Individuals with Disabling Long Covid: 72,000
h5
Cumulative Cost to Jan 31, 2022: $7.1B
h5
% of Population with Long Covid: 6.5%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 394,000
h5
# of Individuals with Disabling Long Covid: 131,000
h5
Cumulative Cost to Jan 31, 2022: $1.3B
h5
% of Population with Long Covid: 6.9%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 72,000
h5
# of Individuals with Disabling Long Covid: 24,000
h5
Cumulative Cost to Jan 31, 2022: $2.4B
h5
% of Population with Long Covid: 6.9%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 131,000
h5
# of Individuals with Disabling Long Covid: 43,500
h5
Cumulative Cost to Jan 31, 2022: $3.5B
h5
% of Population with Long Covid: 6.7%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 195,000
h5
# of Individuals with Disabling Long Covid: 65,000
h5
Cumulative Cost to Jan 31, 2022: $1.5B
h5
% of Population with Long Covid: 6.1%
h5
% of Population with Disabling Long Covid: 2%
h5
# of Individuals with Long Covid: 81,500
h5
# of Individuals with Disabling Long Covid: 27,000
h5
Cumulative Cost to Jan 31, 2022: $11B
h5
% of Population with Long Covid: 7%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 619,000
h5
# of Individuals with Disabling Long Covid: 205,000
h5
Cumulative Cost to Jan 31, 2022: $2.5B
h5
% of Population with Long Covid: 6.8%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 142,000
h5
# of Individuals with Disabling Long Covid: 47,000
h5
Cumulative Cost to Jan 31, 2022: $17.5B
h5
% of Population with Long Covid: 7.2%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 1,400,000
h5
# of Individuals with Disabling Long Covid: 464,000
h5
Cumulative Cost to Jan 31, 2022: $12.6B
h5
% of Population with Long Covid: 7.1%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 716,000
h5
# of Individuals with Disabling Long Covid: 238,000
h5
Cumulative Cost to Jan 31, 2022: $1.2B
h5
% of Population with Long Covid: 8.8%
h5
% of Population with Disabling Long Covid: 2.9%
h5
# of Individuals with Long Covid: 66,500
h5
# of Individuals with Disabling Long Covid: 22,000
h5
Cumulative Cost to Jan 31, 2022: $14B
h5
% of Population with Long Covid: 6.6%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 763,000
h5
# of Individuals with Disabling Long Covid: 253,000
h5
Cumulative Cost to Jan 31, 2022: $8.7B
h5
% of Population with Long Covid: 7.3%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 481,100
h5
# of Individuals with Disabling Long Covid: 160,000
h5
Cumulative Cost to Jan 31, 2022: $12.6B
h5
% of Population with Long Covid: 6.8%
h5
% of Population with Disabling Long Covid: 2.3%
h5
# of Individuals with Long Covid: 702,000
h5
# of Individuals with Disabling Long Covid: 233,000
h5
Cumulative Cost to Jan 31, 2022: $1.1B
h5
% of Population with Long Covid: 4.4%
h5
% of Population with Disabling Long Covid: 1.4%
h5
# of Individuals with Long Covid: 62,000
h5
# of Individuals with Disabling Long Covid: 20,500
h5
Cumulative Cost to Jan 31, 2022: $2B
h5
% of Population with Long Covid: 6.7%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 113,000
h5
# of Individuals with Disabling Long Covid: 37,500
h5
Cumulative Cost to Jan 31, 2022: $16B
h5
% of Population with Long Covid: 10%
h5
% of Population with Disabling Long Covid: 4%
h5
# of Individuals with Long Covid: 860,000
h5
# of Individuals with Disabling Long Covid: 285,000
h5
Cumulative Cost to Jan 31, 2022: $1B
h5
% of Population with Long Covid: 8.4%
h5
% of Population with Disabling Long Covid: 2.8%
h5
# of Individuals with Long Covid: 62,000
h5
# of Individuals with Disabling Long Covid: 21,000
h5
Cumulative Cost to Jan 31, 2022: $9.8B
h5
% of Population with Long Covid: 8%
h5
% of Population with Disabling Long Covid: 2.7%
h5
# of Individuals with Long Covid: 554,000
h5
# of Individuals with Disabling Long Covid: 184,000
h5
Cumulative Cost to Jan 31, 2022: $4.1B
h5
% of Population with Long Covid: 7.7%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 230,000
h5
# of Individuals with Disabling Long Covid: 76,500
h5
Cumulative Cost to Jan 31, 2022: $43B
h5
% of Population with Long Covid: 6.3%
h5
% of Population with Disabling Long Covid: 2.1%
h5
# of Individuals with Long Covid: 2,470,000
h5
# of Individuals with Disabling Long Covid: 817,000
h5
Cumulative Cost to Jan 31, 2022: $6.7B
h5
% of Population with Long Covid: 6.7%
h5
% of Population with Disabling Long Covid: 2.2%
h5
# of Individuals with Long Covid: 370,00
h5
# of Individuals with Disabling Long Covid: 123,000
h5
Cumulative Cost to Jan 31, 2022: $3.7B
h5
% of Population with Long Covid: 5.7%
h5
% of Population with Disabling Long Covid: 1.9%
h5
# of Individuals with Long Covid: 205,000
h5
# of Individuals with Disabling Long Covid: 68,000
h5
Cumulative Cost to Jan 31, 2022: $1.3B
h5
% of Population with Long Covid: 7.7%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 73,000
h5
# of Individuals with Disabling Long Covid: 24,000
h5
Cumulative Cost to Jan 31, 2022: $30B
h5
% of Population with Long Covid: 7.9%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 1,640,000
h5
# of Individuals with Disabling Long Covid: 544,000
h5
Cumulative Cost to Jan 31, 2022: $5.1B
h5
% of Population with Long Covid: 7.4%
h5
% of Population with Disabling Long Covid: 2.5%
h5
# of Individuals with Long Covid: 290,000
h5
# of Individuals with Disabling Long Covid: 96,000
h5
Cumulative Cost to Jan 31, 2022: $14B
h5
% of Population with Long Covid: 6.1%
h5
% of Population with Disabling Long Covid: 2%
h5
# of Individuals with Long Covid: 783,000
h5
# of Individuals with Disabling Long Covid: 260,000
h5
Cumulative Cost to Jan 31, 2022: $1.8B
h5
% of Population with Long Covid: 9.5%
h5
% of Population with Disabling Long Covid: 3.1%
h5
# of Individuals with Long Covid: 100,000
h5
# of Individuals with Disabling Long Covid: 33,000
h5
Cumulative Cost to Jan 31, 2022: $7.2B
h5
% of Population with Long Covid: 8.3%
h5
% of Population with Disabling Long Covid: 2.7%
h5
# of Individuals with Long Covid: 410,000
h5
# of Individuals with Disabling Long Covid: 136,000
h5
Cumulative Cost to Jan 31, 2022: $1.2B
h5
% of Population with Long Covid: 7.8%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 67,000
h5
# of Individuals with Disabling Long Covid: 22,100
h5
Cumulative Cost to Jan 31, 2022: $9.9B
h5
% of Population with Long Covid: 8.3%
h5
% of Population with Disabling Long Covid: 2.8%
h5
# of Individuals with Long Covid: 555,000
h5
# of Individuals with Disabling Long Covid: 184,000
h5
Cumulative Cost to Jan 31, 2022: $33B
h5
% of Population with Long Covid: 6.6%
h5
% of Population with Disabling Long Covid: 2%
h5
# of Individuals with Long Covid: 1,840,000
h5
# of Individuals with Disabling Long Covid: 611,000
h5
Cumulative Cost to Jan 31, 2022: $4.7B
h5
% of Population with Long Covid: 10%
h5
% of Population with Disabling Long Covid: 4%
h5
# of Individuals with Long Covid: 262,000
h5
# of Individuals with Disabling Long Covid: 87,000
h5
Cumulative Cost to Jan 31, 2022: $500M
h5
% of Population with Long Covid: 4.5%
h5
% of Population with Disabling Long Covid: 1.5%
h5
# of Individuals with Long Covid: 28,000
h5
# of Individuals with Disabling Long Covid: 9,000
h5
Cumulative Cost to Jan 31, 2022: $8.2B
h5
% of Population with Long Covid: 5.4%
h5
% of Population with Disabling Long Covid: 1.8%
h5
# of Individuals with Long Covid: 457,000
h5
# of Individuals with Disabling Long Covid: 151,000
h5
Cumulative Cost to Jan 31, 2022: $2.3B
h5
% of Population with Long Covid: 7.2%
h5
% of Population with Disabling Long Covid: 2.4%
h5
# of Individuals with Long Covid: 132,000
h5
# of Individuals with Disabling Long Covid: 44,000
h5
Cumulative Cost to Jan 31, 2022: $8.1B
h5
% of Population with Long Covid: 7.8%
h5
% of Population with Disabling Long Covid: 2.6%
h5
# of Individuals with Long Covid: 450,000
h5
# of Individuals with Disabling Long Covid: 150,000
h5
Cumulative Cost to Jan 31, 2022: $775M
h5
% of Population with Long Covid: 7.5%
h5
% of Population with Disabling Long Covid: 2.5%
h5
# of Individuals with Long Covid: 43,500
h5
# of Individuals with Disabling Long Covid: 14,500
h5
Cumulative Cost to Jan 31, 2022: $6.7B
h5
% of Population with Long Covid: 5.4%
h5
% of Population with Disabling Long Covid: 1.8%
h5
# of Individuals with Long Covid: 394,000
h5
# of Individuals with Disabling Long Covid: 130,000
h5
Cumulative Cost to Jan 31, 2022: $6.5B
h5
% of Population with Long Covid: 7.5%
h5
% of Population with Disabling Long Covid: 2.5%
h5
# of Individuals with Long Covid: 363,000
h5
# of Individuals with Disabling Long Covid: 121,000
h5
Cumulative Cost to Jan 31, 2022: $3.3B
h5
% of Population with Long Covid: 4.6%
h5
% of Population with Disabling Long Covid: 1.5%
h5
# of Individuals with Long Covid: 187,000
h5
# of Individuals with Disabling Long Covid: 62,000


What is SitesDB?

SitesDB is one of the largest databases of websites and domain names on the internet, with over 40 million entries and growing. For more than 12 years, we've been manually verifying and updating website and domain details, combining human expertise with AI-powered systems to ensure the accuracy and relevance of our data.

At SitesDB, we provide in-depth technical and useful information about websites and domains, including:

  • Website meta tags
  • Domain & WHOIS data
  • General backlink and ranking statistics
  • Social media engagement stats
  • Root page speed insights
  • Website content and HTML resources
  • Website safety and security details, sourced from multiple trusted security providers
  • HTTP headers analysis
  • HTML validation reports
  • Lists of similar websites and competitors
  • Website keyword analysis, including top traffic-driving keywords
  • Heading structure (H tags) breakdown
  • Domain variations across different TLDs (Top-Level Domains)

In addition to this data, SitesDB offers a suite of website analysis tools — including Chrome CRUX, Google Lighthouse, and our own AI-enhanced algorithms — to help identify alternative websites, direct competitors, and similar sites, all continuously refined through both automated systems and human review.